We also demonstrated a loss of heterozygosity for TP53 at 17p13 with a frameshift mutation of TP53, suggesting that the high expression of MYC and TP53 dysfunction may contribute to cell survival in DLBCL. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.